Article Text

other Versions

PDF
Original research
Perioperative safety of Hydrosoft coils
  1. Ben Waldau1,
  2. Aquilla S Turk III2,
  3. Parham Yashar3,
  4. Ahmad Khaldi1,
  5. Raymond D Turner IV2,
  6. M Imran Chaudry2,
  7. Adnan H Siddiqui3,
  8. Elad I Levy3,
  9. Brian L Hoh1,
  10. J Mocco1
  1. 1Department of Neurosurgery, University of Florida, Gainesville, FL, USA
  2. 2Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA
  3. 3Department of Neurosurgery and Toshiba Stroke Research Center, University at Buffalo, Buffalo, New York, USA
  1. Correspondence to Dr J Mocco, Department of Neurosurgery, University of Florida, Gainesville, FL, 32610, USA; jmocco{at}neurosurgery.ufl.edu

Abstract

Objective Hydrosoft coils were developed to serve as finishing coils to prevent aneurysmal recurrence at the neck. Initial animal studies were encouraging since some studies showed endothelial healing across the neck without recurrence over time. However, theoretical concerns exist regarding the potential threat to parent vessels as the Hydrosoft coils at the neck expand, as well as whether such coils can be adequately supple to safely serve as a true finishing coil. A retrospective review of the initial clinical experience utilizing Hydrosoft coils from three high-volume centers was performed.

Methods Each center was asked to report angiographic (aneurysmal location, aneurysmal maximal size, neck size, incidence of intraprocedural parent vessel thrombosis, coil herniation, aneurysmal rupture as well as Raymond scale and percent occlusion after coiling) and clinical (rupture status, Hunt and Hess grade, incidence of stroke, hemorrhage, vasospasm and hydrocephalus) data on consecutive patients who underwent placement of Hydrosoft coils.

Results A total of 141 patients were enrolled. Embolization achieved a Raymond Scale score of I (complete obliteration) in 79 aneurysms (56%), II (residual neck) in 40 aneurysms (28%) and III (residual dome) in 21 aneurysms (15%); in one case the Hydrosoft coil could not be placed. Procedural morbidity and mortality were 2.1% and 1.4%, respectively. No complications were definitively attributed to the use of Hydrosoft coils. There were three cases (2.1%) of parent vessel thrombosis, two of which resolved after intraprocedural administration of thrombolytic agents and did not lead to neurological sequelae. The incidences of intraprocedural or periprocedural aneurysmal rupture (2.1%), cerebral hemorrhage (3.5%), stroke (4.9%), vasospasm (26.2%) or hydrocephalus (31.1%) were comparable to contemporary literature.

Conclusion The use of Hydrosoft coils appears to be safe and does not lead to higher complication rates than are currently accepted in the literature. Further prospective studies are required to determine whether the use of Hydrosoft coils results in a lower incidence of aneurysmal recurrence.

  • Hydrosoft
  • coil
  • safety
  • morbidity
  • mortality
  • aneurysm
  • artery
  • MRI
  • CT
  • vein
  • thrombectomy
  • spine
  • subarachnoid
  • technique
  • catheter
  • balloon
  • thrombolysis
  • stroke
  • stent
  • stenosis
  • hemorrhage
  • device
  • brain
  • atherosclerosis
  • angioplasty
  • angiography
  • subdural
  • cranial nerve
  • intervention
  • tumor
  • neck
  • navigation
  • malformation

Statistics from Altmetric.com

Footnotes

  • Correction notice This article has been corrected since it was published Online First. The author affiliations have been updated.

  • Competing interests None.

  • Ethics approval This study was approved by the IRB committees at the University of Florida, Medical University of South Carolina and University at Buffalo.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.